Conference Coverage
Conference Coverage
Combo shows efficacy in platinum-resistant ovarian cancer
Ixabepilone plus bevacizumab improved outcomes, compared with ixabepilone alone.
Conference Coverage
Niraparib maintenance offers continued benefit in some with recurrent ovarian cancer
Benefits were seen in patients with germline BRCA mutations.
Conference Coverage
Can benefits of SBRT outweigh risks in ultra-central lung tumors?
Stereotactic body radiotherapy for ultra-central lung tumors offers good disease control and survival but carries a risk of lung hemorrhage.
Conference Coverage
KRYSTAL-1: Clear activity of adagrasib in KRAS-mutated NSCLC
Phase 1/2 results with adagrasib confirm KRAS G12C as a druggable target in non–small cell lung cancer.
Conference Coverage
Biomarkers predict efficacy of DKN-01 in endometrial cancer
High levels of DKK1 expression and the presence of Wnt or PIK3CA activating mutations are associated with better outcomes.
Conference Coverage
Denosumab now dominant therapy for osteoporosis linked to cancer
In changing patterns of osteoporosis drug prescriptions, denosumab has risen to the top of cancer indications.
Conference Coverage
Gynecologic cancer patients at risk of insurance loss, ‘catastrophic’ costs
The Affordable Care Act did not spare many gynecologic cancer patients from financial hardship.
Conference Coverage
Risk factors predict graft failure in pediatric acute leukemia patients
Conference Coverage
Allo-HSCT plus monoclonal antibody treatment can improve survival in patients with r/r B-ALL
Conference Coverage
Frail status may be better than age for predicting ovarian cancer outcomes
Conference Coverage
COVID-19 can cause atypical thyroid inflammation
Patients with thyroid abnormalities during acute COVID-19, or who develop such symptoms, should have thyroid function checked every 6 months for a...